Pharma and Biotech Daily: Merck's Acquisition, Viking Therapeutics, Orbis Funding, and More!

Pharma and BioTech Daily

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Merck has acquired a Wuxi Biologics facility in Ireland for $500 million, expanding manufacturing operations in the biopharma industry. Analysts predict Viking Therapeutics as a top candidate amid higher M&A activity. Danish biotech Orbis has secured $93 million in funding for developing oral medicines. Evidence is growing on the benefits of GLP-1s in treating heart disease beyond weight loss and blood sugar control. Lilly has opened a new facility to drive innovation in bringing medicines to market, while Novo has filed a citizen petition to block compounded Victoza. Roche has invested $1 billion for another ADC from China. Various job opportunities are available in the industry, with insights on Alzheimer's treatment, Novo vs. Lilly's performance, and updates on FDA decisions and lawsuits related to GLP-1 products.